AstraZeneca cancels £450m vaccine plant in UK

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow ...
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...